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Antimicrobial Effect of Dimethyl sulfoxide and N, N-Dimethylformamide on Mycobacterium abscessus:
Implications for Antimicrobial Susceptibility Testing Zara I. Kirkwood 1,2 , Beverley Cherie Millar 1,2 , Damian G. Downey 1,3 , John E. Moore 1,2 1 Centre for Experimental Medicine, Queen's University, 2 Department of Bacteriology, Northern Ireland Public Health Laboratory, Belfast City Hospital, 3 linked to CF. [5] Recently, NTMs within CF have emerged globally as a significant clinical problem, where estimates of the prevalence of NTM-positive sputum cultures have ranged from 6% to 30%. [7] These organisms are clinically significant due to their virulence, manifesting in greater morbidity and mortality, associated with a more rapid decline in lung function. Simultaneously, antibiotic treatment of these NTMs is complicated by the high level of multiresistance and panresistance associated with clinical isolates from CF patients.
The presence of such high levels of antibiotic resistance in these NTM organisms has thus stimulated research interests in discovering novel sources of antimicrobials, which show activity against these organisms. All isolates had been historically stored on slopes of Lowenstein-Jensen medium in glass universal containers at ambient temperature. All isolates were recovered and passaged twice on Columbia agar base (Oxoid CM0331; Oxoid Ltd., Basingstoke, UK) supplemented with 5% (v/v) defibrinated horse blood, which was incubated at 37°C for 5 days, before employment in the current study. A fresh culture of each isolate was prepared as described above and was harvested into 0.1% (w/v) peptone saline (CM0733) to yield a 0.5 McFarland inoculation standard. Inoculum was streaked onto fresh Columbia agar base (Oxoid CM0331) supplemented with 5% (v/v) defibrinated horse blood and allowed to dry. Following this, 10 μl DMSO (Sigma Aldrich, UK) and DMF (Fluka Ltd., UK) were added carefully in duplicate onto the surface of the preinoculated plate and allowed to dry, before incubation, as detailed above.
In addition, serial dilutions of DMSO and DMF were prepared separately in 0.1% (w/v) peptone saline (CM0733) covering the range 1:10 (10 −1 ), 1:100 (10 −2 ), 1:1000 (10 −3 ), and 1:10,000 (10 −4 ) and were added as above. Peptone saline (0.1% w/v) diluent controls were also included. Inhibition was defined as the diameter of no growth (mm) surrounded by confluent mycobacterial growth. Resulting zones of inhibition were compared statistically between DMSO and DMF at all concentrations tested, where P < 0.05 (5%) was considered statistically significant.
results
Mean inhibition of M. abscesses by varying concentrations of DMSO and DMF is shown in Figure 1 . No inhibitory effect was seen with 0.1% (w/v) peptone saline diluent. With undiluted DMSO, inhibition of 16/17 (94.1%) isolates was noted, while undiluted DMF inhibited all the isolates. However, when the DMSO was diluted 10-fold (1 log), there was no visible inhibition of any of the 17 isolates. In contrast, the DMF was more inhibitory than the DMSO, as inhibition with DMF was observed through to 1:1000 dilution, with no inhibition being observed at a dilution of 1:10,000.
dIscussIon
The emergence of antimicrobial resistance globally has stimulated drug discovery for novel antimicrobial agents or the repurposing of existing drugs. The pipeline of novel antimicrobial molecules may originate from medicinal chemistry, synthetic biology, existing drug repurposing, or from natural sources (phytochemicals) sources. One issue common to each of these sources is the relative inability to find suitable solvent(s), in which to dissolve such novel molecules to enable antimicrobial susceptibility testing. Commonly, such molecules are insoluble in water or aqueous solution, requiring an exploration of suitable organic solvents. DMSO and DMF have been long established solvents used for the solubilization of conventional antibiotics and other difficult-to-dissolve anti-infective molecules. Furthermore, well-established antimicrobial susceptibility testing protocols such as Clinical and Laboratory Standards Institute guidelines recommend the employment of these solvents to dissolve insoluble antibiotics such as ethionamide (DMSO) and rifampin (DMSO or DMF) with Mycobacterium spp. [8] Therefore, it is important to examine any potential antimicrobial effect per se originating from such DMSO and DMF solvents.
Overall, while DMSO and DMF are good solvents to allow solubilization of conventional antibiotics and novel anti-infective molecules under antimicrobial investigation, employment of such solvents is not without risk of inhibiting the bacterial species being examined and the potential reporting of false-positive effects. Researchers employing such solvents should therefore always include an appropriate control in their investigations to detect potential inhibition of bacterial growth.
In conclusion, from this study and when working with M. abscessus, DMSO should not be used undiluted and should be diluted by at least 1:10 (10-fold), whereas DMF should also not be used undiluted but should be diluted by at least 1:10,000 (10,000-fold) to avoid inhibition of organisms from such solvents.
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